Article
RNA Interference inhibits hepatitis B virus of different genotypes in vitro and in vivo.
BMC microbiology - 10 Aug 2010
Zhang Ya-Li, Cheng Tong, Cai Yi-Jun, Yuan Quan, Liu Che, Zhang Tao, Xia De-Zhen, Li Rui-Yin, Yang Lian-Wei, Wang Ying-Bin, Yeo Anthony E T, Shih James Wai-Kuo, Zhang Jun, Xia Ning-Shao
Abstract excerpt
BACKGROUND: Hepatitis B virus (HBV) infection increases the risk of liver disease and hepatocellular carcinoma. Small interfering RNA (siRNA) can be a potential new tool for HBV therapy. Given the high heterogeneity of HBV strains and the sensitivity towards sequences changes of siRNA, finding a potent siRNA inhibitor against the conservative site on the HBV genome is essential to ensure a therapeutic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
